{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T18:55:45Z","timestamp":1776711345701,"version":"3.51.2"},"publisher-location":"Cham","reference-count":11,"publisher":"Springer Nature Switzerland","isbn-type":[{"value":"9783031722295","type":"print"},{"value":"9783031722301","type":"electronic"}],"license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025]]},"DOI":"10.1007\/978-3-031-72230-1_62","type":"book-chapter","created":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T11:38:39Z","timestamp":1753875519000},"page":"353-356","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Global Treatment Approaches Part 2: Optogenetics and Retinal Implants"],"prefix":"10.1007","author":[{"given":"Gareth D.","family":"Mercer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian G.","family":"Ballios","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter J.","family":"Kertes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,7,31]]},"reference":[{"issue":"6","key":"62_CR1","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1016\/j.clinph.2019.11.029","volume":"131","author":"LN Ayton","year":"2020","unstructured":"Ayton LN, Barnes N, Dagnelie G, Fujikado T, Goetz G, Hornig R, Jones BW, Muqit MMK, Rathbun DL, Stingl K, Weiland JD, Petoe MA. An update on retinal prostheses. Clin Neurophysiol. 2020;131(6):1383-1398. https:\/\/doi.org\/10.1016\/j.clinph.2019.11.029.","journal-title":"Clin Neurophysiol."},{"key":"62_CR2","doi-asserted-by":"publisher","unstructured":"Bi A, Cui J, Ma Y, Olshevskaya E, Pu M, Dizhoor A, et al. Ectopic expression of a microbial-type rhodopsin restores visual responses in mice with photoreceptor degeneration. Neuron. 2006;50:23\u201333. https:\/\/doi.org\/10.1016\/j.neuron.2006.02.026","DOI":"10.1016\/j.neuron.2006.02.026"},{"issue":"10","key":"62_CR3","doi-asserted-by":"publisher","first-page":"2248","DOI":"10.1016\/j.ophtha.2016.06.049","volume":"123","author":"L da Cruz","year":"2016","unstructured":"da Cruz L, Dorn JD, Humayun MS, Dagnelie G, Handa J, Barale PO, Sahel JA, Stanga PE, Hafezi F, Safran AB, Salzmann J, Santos A, Birch D, Spencer R, Cideciyan AV, de Juan E, Duncan JL, Eliott D, Fawzi A, Olmos de Koo LC, Ho AC, Brown G, Haller J, Regillo C, Del Priore LV, Arditi A, Greenberg RJ; Argus II Study Group. Five-Year Safety and Performance Results from the Argus II Retinal Prosthesis System Clinical Trial. Ophthalmology. 2016;123(10):2248-54. https:\/\/doi.org\/10.1016\/j.ophtha.2016.06.049.","journal-title":"Ophthalmology."},{"issue":"8","key":"62_CR4","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1016\/j.ophtha.2015.04.032","volume":"122","author":"AC Ho","year":"2015","unstructured":"Ho AC, Humayun MS, Dorn JD, da Cruz L, Dagnelie G, Handa J, Barale PO, Sahel JA, Stanga PE, Hafezi F, Safran AB, Salzmann J, Santos A, Birch D, Spencer R, Cideciyan AV, de Juan E, Duncan JL, Eliott D, Fawzi A, Olmos de Koo LC, Brown GC, Haller JA, Regillo CD, Del Priore LV, Arditi A, Geruschat DR, Greenberg RJ; Argus II Study Group. Long-Term Results from an Epiretinal Prosthesis to Restore Sight to the Blind. Ophthalmology. 2015;122(8):1547-54. https:\/\/doi.org\/10.1016\/j.ophtha.2015.04.032.","journal-title":"Ophthalmology."},{"issue":"6","key":"62_CR5","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1038\/nn.2117","volume":"11","author":"P Lagali","year":"2008","unstructured":"Lagali P, Balya D, Awatramani G, M\u00fcnch T, Kim D, Busskamp V, et al. Light-activated channels targeted to ON bipolar cells restore visual function in retinal degeneration. Nat Neurosci. 2008;11(6):667\u201375.","journal-title":"Nat Neurosci."},{"key":"62_CR6","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1007\/978-981-15-8763-4_38","volume":"1293","author":"Q Lu","year":"2021","unstructured":"Lu Q, Pan Z. Optogenetic Strategies for Vision Restoration. Adv Exp Med Biol. 2021;1293:545\u201355.","journal-title":"Adv Exp Med Biol."},{"key":"62_CR7","unstructured":"Nanoscope Therapeutics Announces Presentation of Key Results from Phase 2b RESTORE Trial of MCO-010 for the Treatment of Retinitis Pigmentosa at the ARVO Annual Meeting. Nanoscope therapeutics, Dallas TX, April 27, 2023. Webpage retrieved May 28, 2023. <https:\/\/nanostherapeutics.com\/2023\/04\/27\/nanoscope-therapeutics-announces-presentation-of-key-results-from-phase-2b-restore-trial-of-mco-010-for-the-treatment-of-retinitis-pigmentosa-at-the-arvo-annual-meeting\/>"},{"issue":"7","key":"62_CR8","first-page":"1106","volume":"63","author":"JS Sahel","year":"2022","unstructured":"Sahel JS, Audo IS, Boulanger-Scemama E, Pagot C, Arleo A, Martel JN, Esposti SD, Delaux A, de Saint Aubert JP, de Montleau C, Gutman E, Duebel J, Picaud S, Dalkara D, Taiel M, Roska B. Optogenetics in the clinic: safety and efficacy updates on the phase 1\/2 clinical trial PIONEER. Invest. Ophthalmol. Vis. Sci. 2022;63(7):1106.","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"62_CR9","doi-asserted-by":"publisher","first-page":"7658","DOI":"10.1167\/iovs.13-12835","volume":"54","author":"K Stingl","year":"2013","unstructured":"Stingl K, Bartz-Schmidt K-U, Gekeler F, Kusnyerik A, Sachs H, Zrenner E. Functional outcome in subretinal electronic implants depends on foveal eccentricity. Invest Ophthalmol Vis Sci. 2013;54:7658\u20137665. https:\/\/doi.org\/10.1167\/iovs.13-12835.","journal-title":"Invest Ophthalmol Vis Sci."},{"key":"62_CR10","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1007\/978-981-15-8763-4_37","volume":"1293","author":"H Tomita","year":"2021","unstructured":"Tomita H, Sugano E. Optogenetics-Mediated Gene Therapy for Retinal Diseases. Adv Exp Med Biol. 2021;1293:535\u201343.","journal-title":"Adv Exp Med Biol."},{"key":"62_CR11","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.preteyeres.2016.05.002","volume":"53","author":"L Yue","year":"2016","unstructured":"Yue L, Weiland JD, Roska B, Humayun MS. Retinal stimulation strategies to restore vision: Fundamentals and systems. Prog Retin Eye Res. 2016;53:21-47. https:\/\/doi.org\/10.1016\/j.preteyeres.2016.05.002","journal-title":"Prog Retin Eye Res."}],"container-title":["Advances in Experimental Medicine and Biology","Atlas of Inherited Retinal Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-031-72230-1_62","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T18:35:32Z","timestamp":1776710132000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-3-031-72230-1_62"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"ISBN":["9783031722295","9783031722301"],"references-count":11,"URL":"https:\/\/doi.org\/10.1007\/978-3-031-72230-1_62","relation":{},"ISSN":["0065-2598","2214-8019"],"issn-type":[{"value":"0065-2598","type":"print"},{"value":"2214-8019","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025]]},"assertion":[{"value":"31 July 2025","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}